Galectin (GALT) Posts Q2 Loss of 17c/Share
Tweet
Share
E-mailGet Alerts GALT Hot Sheet
Join SI Premium – FREE
Galectin (NASDAQ: GALT) reported Q2 EPS of ($0.17), $0.04 better than the analyst estimate of ($0.21).
For earnings history and earnings-related data on Galectin (GALT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Netflix climbs following Ackman stake, up 1.8%
- BK Technologies (BKTI) Tops Q2 EPS by 11c
- Pelthos Therapeutics Inc. (PTHS) Misses Q2 EPS by 611c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
